Professional Experience
Prof. Dr. Sağlam has held various significant positions throughout his career:
- Current Position: Clinical Oncologist at Gayrettepe Florence Nightingale Hospital, Istanbul
- Previous Roles:
- Medical Oncologist at Metropolitan Florence Nightingale Hospital, Istanbul (1999–2001)
- Physician at Bayraktar Dialysis Center, Istanbul (1997–1998)
Academic Contributions
Prof. Dr. Sağlam is actively involved in academic and research activities:
- Conducted studies on gastrointestinal cancers
- Developed a patented method to reduce chemotherapy toxicity
- Participated in clinical trials and observational studies related to oncology
Areas of Expertise
Prof. Dr. Sağlam specializes in the treatment of various cancers, with a patient-centric approach:
- Gastrointestinal Cancers: Including stomach, colon, and rectal cancers
- Breast Cancer: Comprehensive treatment plans tailored to individual needs
- Pancreatic Cancer: Utilizing advanced chemotherapy protocols
- Prostate and Lung Cancers: Offering both chemotherapy and immunotherapy options
Publications and Research
Prof. Dr. Sağlam has contributed to numerous peer-reviewed journals, highlighting his research acumen:
- Topuz E, Eralp Y, Sağlam S, et al. “Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer.” Gynecologic Oncology. 2004;92(1):147–5.
- Balci NC, Akun E, Erturk M, Sağlam S, et al. “Renal-related perinephric fluid collections: MRI findings.” Magnetic Resonance Imaging. 2005;23(5):679–84.
- Basaran M, Bavbek ES, Sağlam S, et al. “A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.” Oncology. 2007;72(3–4):255–60.
Patient Care Philosophy
Prof. Dr. Sağlam emphasizes a holistic approach to patient care:
- Prioritizes clear communication and patient education
- Offers online consultations for international patients
- Focuses on reducing treatment side effects to improve quality of life
- Developed the “LIP method” for treating leptomeningeal metastases, enhancing patient outcomes
Professional Affiliations
Prof. Dr. Sağlam is affiliated with several esteemed medical organizations:
- Turkish Medical Oncology Association
- European Neuroendocrine Tumor Society (ENETS)
- European Society of Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
FAQs
- Is Dr. Sezer Sağlam board-certified?
- Yes, Prof. Dr. Sağlam is board-certified in medical oncology.
- What types of treatments does he offer?
- He provides chemotherapy and immunotherapy for various cancers, including gastrointestinal, breast, pancreatic, prostate, and lung cancers.
- Does he treat international patients?
- Yes, he offers online consultations and treatment plans for international patients.
- How long is the typical hospital stay for chemotherapy?
- The duration varies based on the treatment protocol, but many chemotherapy sessions are administered on an outpatient basis.
- What languages does he speak?
- Prof. Dr. Sağlam is fluent in English and Turkish.
- Has he received any notable awards?
- Yes, he was nominated for the International Best Researcher Award in 2024 for his research on hepatocellular carcinoma in liver-transplanted patients.
